Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Reumatologia|December 16, 2024
Nutritional disorders and nutrition-related conditions: an underestimated clinical problem in systemic sclerosisAnna Wojteczek, Michał Chmielewski, Zbigniew Zdrojewski
Clinical Rheumatology|November 18, 2019
Prevalence of malnutrition in systemic sclerosis patients assessed by different diagnostic toolsAnna Wojteczek, Jolanta A Dardzińska, Sylwia Małgorzewicz, et al.
Journal of Clinical Medicine|September 28, 2021
Lung Ultrasound in the Screening of Pulmonary Interstitial Involvement Secondary to Systemic Connective Tissue Disease: A Prospective Pilot Study Involving 180 PatientsNatalia Buda, Anna Wojteczek, Anna Masiak, et al.
Frontiers in Molecular Biosciences|November 16, 2020
Metabolic Pattern of Systemic Sclerosis: Association of Changes in Plasma Concentrations of Amino Acid-Related Compounds With Disease PresentationZaneta Smolenska, Magdalena Zabielska-Kaczorowska, Anna Wojteczek, et al.
Diagnostics (Basel, Switzerland)|March 3, 2021
Clinical Impact of Vertical Artifacts Changing with Frequency in Lung UltrasoundNatalia Buda, Agnieszka Skoczylas, Marcello Demi, et al.
Annales Academiae Medicae Stetinensis|April 4, 2013
[Macrophage activation syndrome: report on three cases]Marcin Zietkiewicz, Adam Hajduk, Anna Wojteczek, et al.
Nutrients|August 29, 2024
High-Protein Nutritional Supplements Improve Nutritional Status in Malnourished Patients with Systemic SclerosisAnna Wojteczek, Jolanta Dardzińska, Marcin Ziętkiewicz, et al.
Diagnostics (Basel, Switzerland)|February 13, 2025
Cardiac Morpho-Functional Changes, Inflammation and Fibrosis in Systemic Sclerosis-A Pilot Study of a Tertiary Center CohortKarolina Dorniak, Zuzanna Gogulska, Alessandro Viti, et al.
Rheumatology (Oxford, England)|January 31, 2024
A phase 2 trial investigating the efficacy and safety of the mPGES-1 inhibitor vipoglanstat in systemic sclerosis-related Raynaud'sGöran Tornling, Charlotte Edenius, John D Pauling, et al.
Rheumatology (Oxford, England)|April 8, 2026
Clinical characteristics and risk factors for calcinosis cutis in systemic sclerosis: insights from the EUSTAR databaseAslihan Avanoglu-Guler, Michael Hughes, Giacomo De Luca, et al.
Pageof 2